2021
DOI: 10.4103/pm.pm_94_21
|View full text |Cite
|
Sign up to set email alerts
|

Naringin, a natural flavonone glycoside attenuates N-nitrosodiethylamine- induced hepatocellular carcinoma in sprague-dawley rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…Naringin has well-documented efficacy against LPO [55]. Acharya et al [43] also reported that naringin dose-dependently reduced oxidative damage markers, including the LPO marker MDA, consistent with free radical scavenging activity. This suppression of ROS accumulation and enhanced antioxidant capacity also prevents carcinogens from being metabolically activated [56] and decreases ROS-induced mtDNA damage (Figure 9) [57,58].…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…Naringin has well-documented efficacy against LPO [55]. Acharya et al [43] also reported that naringin dose-dependently reduced oxidative damage markers, including the LPO marker MDA, consistent with free radical scavenging activity. This suppression of ROS accumulation and enhanced antioxidant capacity also prevents carcinogens from being metabolically activated [56] and decreases ROS-induced mtDNA damage (Figure 9) [57,58].…”
Section: Discussionmentioning
confidence: 81%
“…Similarly, total bilirubin is released due to nonspecific changes in hepatocyte plasma membrane integrity and/or permeability, while ALP elevation results from pathological alterations in biliary flow [42]. All of these increases were reversed by naringin and NDNP, suggesting that these compounds are able to prevent loss of membrane integrity in addition to their effects on the preservation of hepatic functions, such as albumin synthesis [43]. Notably, the nanoformula was more potent in improving liver function and structural integrity than free naringin, likely due to improved bioavailability in liver.…”
Section: Discussionmentioning
confidence: 99%
“…showed a damaged architecture with irregular and larger hepatocytes consisting of prominent nuclei in Sprague–Dawley rats. Treatment with naringin at 30 and 60 mg/kg/day reversed the damaged hepatic architecture and lobules as fewer pyknotic nuclei were observed along with focal degeneration and mild necrosis (Acharya et al, 2021). Rats also showed the presence of more than one nucleolus, darkened nuclei with variable size, intranuclear vacuoles, enlarged fatty change, loss of lobular architecture, proliferation of bile duct, necrosis, dilatation of hepatic sinusoids with Kupffer cell, and hyperplasia (Akshatha et al, 2018).…”
Section: Biochemical Enzymes Affected By Ndeamentioning
confidence: 99%